Jun Chen1, Marina Miller2, Hirotoshi Unno2, Peter Rosenthal2, Michael J Sanderson3, David H Broide4. 1. Division of Pulmonary Diseases, State Key Laboratory of Biotherapy, and the Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Mass. 2. Department of Medicine, University of California, San Diego, La Jolla, Calif. 3. Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Mass. 4. Department of Medicine, University of California, San Diego, La Jolla, Calif. Electronic address: dbroide@ucsd.edu.
Abstract
BACKGROUND: Airway hyperresponsiveness is a major feature of asthma attributed predominantly to an extrinsic immune/inflammatory response increasing airway smooth muscle (ASM) contractility. OBJECTIVE: We investigated whether increased ASM expression of orosomucoid-like 3 (ORMDL3), a gene on chromosome 17q21 highly linked to asthma, induced increased ASM proliferation and contractility in vitro and influenced airway contractility and calcium flux in ASM in precision-cut lung slices (PCLSs) from wild-type and hORMDL3Zp3-Cre mice (which express increased levels of human ORMDL3 [hORMDL3]). METHODS: Levels of ASM proliferation and contraction were assessed in ASM cells transfected with ORMDL3 in vitro. In addition, airway contractility and calcium oscillations were quantitated in ASM cells in PCLSs derived from naive wild-type and naive hORMDL3Zp3-Cre mice, which do not have a blood supply. RESULTS: Increased ASM expression of ORMDL3 in vitro resulted in increased ASM proliferation and contractility. PCLSs derived from naive hORMDL3Zp3-Cre mice, which do not have airway inflammation, exhibit increased airway contractility with increased calcium oscillations in ASM cells. Increased ASM ORMDL3 expression increases levels of ASM sarcoplasmic reticulum Ca2+ ATPase 2b (SERCA2b), which increases ASM proliferation and contractility. CONCLUSION: Overall, these studies provide evidence that an intrinsic increase in ORMDL3 expression in ASM can induce increased ASM proliferation and contractility, which might contribute to increased airway hyperresponsiveness in the absence of airway inflammation in asthmatic patients.
BACKGROUND:Airway hyperresponsiveness is a major feature of asthma attributed predominantly to an extrinsic immune/inflammatory response increasing airway smooth muscle (ASM) contractility. OBJECTIVE: We investigated whether increased ASM expression of orosomucoid-like 3 (ORMDL3), a gene on chromosome 17q21 highly linked to asthma, induced increased ASM proliferation and contractility in vitro and influenced airway contractility and calcium flux in ASM in precision-cut lung slices (PCLSs) from wild-type and hORMDL3Zp3-Cre mice (which express increased levels of humanORMDL3 [hORMDL3]). METHODS: Levels of ASM proliferation and contraction were assessed in ASM cells transfected with ORMDL3 in vitro. In addition, airway contractility and calcium oscillations were quantitated in ASM cells in PCLSs derived from naive wild-type and naive hORMDL3Zp3-Cre mice, which do not have a blood supply. RESULTS: Increased ASM expression of ORMDL3 in vitro resulted in increased ASM proliferation and contractility. PCLSs derived from naive hORMDL3Zp3-Cre mice, which do not have airway inflammation, exhibit increased airway contractility with increased calcium oscillations in ASM cells. Increased ASMORMDL3 expression increases levels of ASM sarcoplasmic reticulum Ca2+ ATPase 2b (SERCA2b), which increases ASM proliferation and contractility. CONCLUSION: Overall, these studies provide evidence that an intrinsic increase in ORMDL3 expression in ASM can induce increased ASM proliferation and contractility, which might contribute to increased airway hyperresponsiveness in the absence of airway inflammation in asthmatic patients.
Authors: Polina L Yarova; Alecia L Stewart; Venkatachalem Sathish; Rodney D Britt; Michael A Thompson; Alexander P P Lowe; Michelle Freeman; Bharathi Aravamudan; Hirohito Kita; Sarah C Brennan; Martin Schepelmann; Thomas Davies; Sun Yung; Zakky Cholisoh; Emma J Kidd; William R Ford; Kenneth J Broadley; Katja Rietdorf; Wenhan Chang; Mohd E Bin Khayat; Donald T Ward; Christopher J Corrigan; Jeremy P T Ward; Paul J Kemp; Christina M Pabelick; Y S Prakash; Daniela Riccardi Journal: Sci Transl Med Date: 2015-04-22 Impact factor: 17.956
Authors: Anne-Marie Lauzon; Jason H T Bates; Graham Donovan; Merryn Tawhai; James Sneyd; Michael J Sanderson Journal: Front Physiol Date: 2012-06-11 Impact factor: 4.566
Authors: Yiping Liu; Yury A Bochkov; Jens C Eickhoff; Tianchen Hu; Nicholas A Zumwalde; Jin Wen Tan; Christopher Lopez; Paul S Fichtinger; Thiruchelvi R Reddy; Katherine A Overmyer; Jennifer E Gumperz; Joshua Coon; Sameer K Mathur; James E Gern; Judith A Smith Journal: Am J Respir Cell Mol Biol Date: 2020-06 Impact factor: 6.914
Authors: Marina Miller; Peter Rosenthal; Ning Weng; Alex Pham; Gyu-Young Hur; John Elliot; Francis H Y Green; Alan James; David H Broide Journal: Clin Exp Allergy Date: 2020-08-05 Impact factor: 5.018
Authors: Hong Dang; Deepika Polineni; Rhonda G Pace; Jaclyn R Stonebraker; Harriet Corvol; Garry R Cutting; Mitchell L Drumm; Lisa J Strug; Wanda K O'Neal; Michael R Knowles Journal: PLoS One Date: 2020-11-30 Impact factor: 3.240
Authors: Hongsheng Gui; Albert M Levin; Donglei Hu; Patrick Sleiman; Shujie Xiao; Angel C Y Mak; Mao Yang; Andrea J Barczak; Scott Huntsman; Celeste Eng; Samantha Hochstadt; Ellen Zhang; Kyle Whitehouse; Samantha Simons; Whitney Cabral; Sami Takriti; Gonçalo Abecasis; Thomas W Blackwell; Hyun Min Kang; Deborah A Nickerson; Soren Germer; David E Lanfear; Frank Gilliland; W James Gauderman; Rajesh Kumar; David J Erle; Fernando D Martinez; Hakon Hakonarson; Esteban G Burchard; L Keoki Williams Journal: Am J Respir Crit Care Med Date: 2021-02-15 Impact factor: 21.405